Nautilus Biotechnology (NAUT) Net Cash Flow (QoQ) (2020 - 2026)
Nautilus Biotechnology (NAUT) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Nautilus Biotechnology | 224.14 Mn | 224.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 119.48% |
| Dec 31, 2025 | -8.55% |
| Sep 30, 2025 | -968.09% |
| Jun 30, 2025 | -78.20% |
| Mar 31, 2025 | -75.93% |
| Dec 31, 2024 | 213.48% |
| Sep 30, 2024 | -2,326.07% |
| Jun 30, 2024 | -113.33% |
| Mar 31, 2024 | 111.57% |
| Dec 31, 2023 | -4,143.39% |
| Sep 30, 2023 | 108.61% |
| Jun 30, 2023 | 39.63% |
| Mar 31, 2023 | 64.98% |
| Dec 31, 2022 | -246.83% |
| Sep 30, 2022 | -198.57% |
| Jun 30, 2022 | 623.68% |
| Mar 31, 2022 | 168.37% |
| Dec 31, 2021 | 95.53% |
| Sep 30, 2021 | -141.48% |
| Jun 30, 2021 | 1,456.88% |